Comparison of Priority vs Standard US Food and Drug Administration Premarket Approval Review for High-Risk Medical Devices

Ítems similars

• Characteristics of Clinical Studies Used for US Food and Drug Administration Approval of High-Risk Medical Device Supplements
  per: Zheng, Sarah Y., et al.
  Publicat: (2017)
• Assessment of Clinical Trial Evidence for High-Risk Cardiovascular Devices Approved Under the Food and Drug Administration Priority Review Program
  per: Jones, L. Camille, et al.
  Publicat: (2018)
• Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications
  per: Lee, Samuel J., et al.
  Publicat: (2021)
• Inclusion of Demographic-Specific Information in Studies Supporting US Food & Drug Administration Approval of High-Risk Medical Devices
  per: Dhruva, Sanket S., et al.
  Publicat: (2017)
• Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017
  per: Dubin, Jonathan R., et al.
  Publicat: (2021)